State Of Wisconsin Investment Board Esperion Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $7,045 - $35,229	-4,826 Reduced 8.52%	51,830 $82,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $42,063 - $70,244	8,264 Added 17.08%	56,656 $352,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $489,764 - $730,602	-89,865 Reduced 65.0%	48,392 $324,000
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $151,480 - $211,819	31,757 Added 29.82%	138,257 $879,000
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $355,710 - $592,140	106,500 New	106,500 $494,000
Q4 2021 Feb 11, 2022	SELL	$4.81 - $11.92 $167,388 - $414,816	-34,800 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $55,264 - $81,158	-2,200 Reduced 5.95%	34,800 $976,000
Q4 2020 Feb 03, 2021	SELL	$24.2 - $35.76 $111,320 - $164,496	-4,600 Reduced 11.06%	37,000 $962,000
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $68,596 - $115,962	2,200 Added 5.58%	41,600 $1.55 Million
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $9,012 - $15,393	300 Added 0.77%	39,400 $2.02 Million
Q1 2020 May 06, 2020	BUY	$27.44 - $73.84 $46,648 - $125,528	1,700 Added 4.55%	39,100 $1.23 Million
Q3 2019 Nov 12, 2019	BUY	$34.47 - $47.53 $168,903 - $232,897	4,900 Added 15.08%	37,400 $1.37 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $28,070 - $36,631	700 Added 2.2%	32,500 $1.51 Million
Q1 2019 May 13, 2019	BUY	$40.11 - $53.57 $336,924 - $449,988	8,400 Added 35.9%	31,800 $1.28 Million
Q4 2018 Feb 11, 2019	BUY	$36.99 - $59.11 $3,699 - $5,911	100 Added 0.43%	23,400 $1.08 Million
Q2 2018 Aug 03, 2018	BUY	$36.2 - $76.4 $228,060 - $481,320	6,300 Added 37.06%	23,300 $913,000
Q1 2018 May 07, 2018	BUY	$65.94 - $80.76 $395,640 - $484,560	6,000 Added 54.55%	17,000 $1.23 Million
Q3 2017 Nov 01, 2017	BUY	$43.8 - $52.77 $481,799 - $580,470	11,000	11,000 $551,000

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account